Sign in

CIK 0001652130 · Large accelerated filer

Intellia Therapeutics, Inc.

Sign in to watch
Ticker
NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364785571
Phone
857-285-6200
Business address
400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
  1. 4 Open-market sale EVP, General Counsel sold 5,615 shares at an average $24.20 ($135,883)
  2. 4 Open-market sale President and CEO sold 5,000 shares at $21.83 ($109,150)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 8-K Event Executive or director change
  6. 4 Open-market sale EVP, General Counsel sold 5,615 shares at $21.04 ($118,140)
  7. 4 Open-market sale President and CEO sold 5,000 shares at $21.83 ($109,150)
  8. CT ORDER Other Confidential Order
  9. SC 13D/A Stake Beneficial Ownership Report
  10. 4 Open-market sale EVP, General Counsel sold 5,615 shares at $21.00 ($117,915)
  11. 4 Open-market sale President and CEO sold 5,000 shares at $21.83 ($109,150)
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 4 Open-market sale EVP, General Counsel sold 5,615 shares at $22.70 ($127,461)
  15. 4 Open-market sale President and CEO sold 5,000 shares at $21.83 ($109,150)
  16. 4 Derivatives Options or other derivatives
  17. 8-K Event Shareholder vote results
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 22 of 37 · 725 filings